Who are Tc-99m Pentetate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Tc 99m filtered sulfur colloid, Iobenguane I -123 Injection, PET MPI.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tc-99m-pentetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Tc-99m Pentetate — Competitive Intelligence Brief

Tc-99m Pentetate (Tc-99m Pentetate) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Radiopharmaceutical diagnostic agent. Area: Diagnostic Imaging / Nuclear Medicine.

marketed Radiopharmaceutical diagnostic agent Diagnostic Imaging / Nuclear Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Tc-99m Pentetate (Tc-99m Pentetate) — NYU Langone Health. Tc-99m Pentetate is a radiopharmaceutical that binds to transferrin in the blood and is filtered by the kidneys, allowing visualization of renal function and urinary tract anatomy via nuclear imaging.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Tc-99m Pentetate TARGET	Tc-99m Pentetate	NYU Langone Health	marketed	Radiopharmaceutical diagnostic agent
Tc 99m filtered sulfur colloid	Tc 99m filtered sulfur colloid	Memorial Health University Medical Center	marketed	Radiopharmaceutical diagnostic agent
Iobenguane I -123 Injection	Iobenguane I -123 Injection	GE Healthcare	phase 3	Radiopharmaceutical diagnostic agent	Norepinephrine transporter (NET)
PET MPI	PET MPI	GE Healthcare	phase 3	Radiopharmaceutical diagnostic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Radiopharmaceutical diagnostic agent class)

GE Healthcare · 2 drugs in this class
Memorial Health University Medical Center · 1 drug in this class
NYU Langone Health · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tc-99m Pentetate — Competitive Intelligence Brief. https://druglandscape.com/ci/tc-99m-pentetate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab